Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Patrick Hurban, Ph.D. | January 20, 2016

Precision Medicine: Applying Genomics Outside of Oncology

Part two
Genomic technologies have been widely adopted within oncology, according to Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions. In the second video from a three-part series, Hurban discusses the use of genomics in oncology trials and many other therapeutic areas as well.

Watch Part one: Precision Medicine – Leveraging Genomics in Clinical Research
Watch Part three: Genomics throughout the Drug Development Process

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer.

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

Read More